Fri.Dec 24, 2021

article thumbnail

What Changes To Your Lifestyle Need To Be Done After Bariatric Surgery

Pharma Mirror

Getting bariatric surgery is a lifesaver for many people. It can dramatically improve the quality of life of those that are having problems because of their obesity. It reduces and even eliminates diabetes in many people and seriously reduces the risk of heart disease. The weight loss can be dramatic as well. Starting almost immediately after the surgery, the pounds fall away with ease.

130
130
article thumbnail

Biogen, Eisai Alzheimer’s drug lecanemab fast tracked by FDA

pharmaphorum

Biogen and Eisai head towards the end of the year with some much-needed good news in their Alzheimer’s programmes, as the FDA awards a fast-track designation to lecanemab, their follow-up to recently approved Aduhelm. The anti-amyloid drug, which also claimed a breakthrough tag from the FDA in July, is being developed for the treatment of early-stage Alzheimer’s disease.

Drugs 109
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate

Scienmag

The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicates they remained at high risk for hospitalization and death. The study, published Dec. 24 in Annals of Oncology showed that fully vaccinated patients who experienced breakthrough infections had a hospitalization rate of […].

article thumbnail

Insights from the WHO’s Global Strategy on Digital Health event

pharmaphorum

The World Health Organization (WHO) recently held a virtual panel discussion during Digital Health Week with speakers from around the world to talk about global strategy on digital health and collective opportunities for catalysing collaborative action. The panel focused on the objectives of the WHO’s Global Strategy on Digital Health 2020-2025 , which aims to develop partnerships at national, regional and global levels to align resources and investments to focus on sustainability and grow

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

December 24: The Weary World Rejoices

Pharma Packaging Solutions

So he came and proclaimed peace to you who were far off and peace to those who were near, for through him both of us have access in one Spirit to the Father. So then you are no longer strangers and aliens, but you are citizens with the saints and also members of the household of God. Ephesians 2:17-19 NRSV God’s purpose and longing for his creation has always been that we might not only be recipients of his great love and peace, but that we might be his partners in bringing that love and peace t

52
article thumbnail

New tentative approval for Hospira Inc drug bortezomib

Drug Patent Watch

[![bortezomib structure]([link] Bortezomib is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Dr Reddys Labs Ltd, and Fresenius Kabi Usa and, and is included in three…. The post New tentative approval for Hospira Inc drug bortezomib appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40

More Trending

article thumbnail

CENTOGENE Wins Award in Digital Healthcare Innovation for Artificial Intelligence (AI) Platform Leading Biomarker Discovery

Drug Discovery Today

Leveraging AI to Accelerate the Path From Diagnosis to Cure

40
article thumbnail

Roche COVID-19 At-Home Test granted FDA Emergency Use Authorization to expand access to rapid self-testing solutions in the United States

BioTech 365

Roche COVID-19 At-Home Test granted FDA Emergency Use Authorization to expand access to rapid self-testing solutions in the United States Roche COVID-19 At-Home Test granted FDA Emergency Use Authorization to expand access to rapid self-testing solutions in the United States … Continue reading →

40
article thumbnail

Which pharmaceutical companies have the most lotion dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most lotion dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most lotion dosed drugs…. The post Which pharmaceutical companies have the most lotion dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, Receives Special Approval for Emergency in Japan

BioTech 365

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, Receives Special Approval for Emergency in Japan Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, Receives Special Approval for Emergency in Japan Japan’s Ministry of Health, Labor and … Continue reading →

52
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Mydecine, Maya team up on digital tools for psychedelic drugs

pharmaphorum

Psychedelic medicines developer Mydecine has joined forces with digital health company Maya to make digital tools that will be used alongside its drug candidates for mental health and addiction disorders. The aim is to develop the digital therapeutics (DTx) and new drug therapies in tandem, so that they can be co-prescribed by physicians and – at least in theory – improve the effectiveness of treatment.

Drugs 119
article thumbnail

Microbix Receives $4.7 Million Order for Viral Transport Medium

BioTech 365

Microbix Receives $4.7 Million Order for Viral Transport Medium Microbix Receives $4.7 Million Order for Viral Transport Medium Follow-on Order from Government of Ontario Procurement Authorities MISSISSAUGA, Ontario, Dec. 24, 2021 (GLOBE NEWSWIRE) — Microbix Biosystems Inc.

40
article thumbnail

Boehringer’s spesolimab data raises hope for serious skin disease

pharmaphorum

Fresh from being awarded a fast-track review from the FDA, Boehringer Ingelheim’s spesolimab has shown encouraging efficacy in a phase 2 trial in generalised pustular psoriasis (GPP), a rare and life-threatening skin disorder. GPP is very different from the more common plaque psoriasis, not least because it causes episodes (flares) of widespread eruptions of painful blisters, which can cause patients to be hospitalised with serious complications, including heart failure, renal failure and

Trials 101
article thumbnail

Avicanna Completes First Commercial Export of CBG Into the European Union

BioTech 365

Avicanna Completes First Commercial Export of CBG Into the European Union Avicanna Completes First Commercial Export of CBG Into the European Union First commercial export of Cannabigerol (CBG), a rare cannabinoid, into Czech Republic This export represents the 14thinternational market … Continue reading →

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

UK study finds Omicron cases less likely to be hospitalised

pharmaphorum

People infected with the Omicron variant of COVID-19 are 50% to 70% less likely to be admitted to hospital than those infected with other variants, according to a UK study. The new analysis from the UK Health Security Agency (UKHSA) also says Omicron infections are estimated to be between 31% to 45% less likely to lead to an emergency room visit than Delta.

article thumbnail

aTyr Pharma Appoints Danielle Campbell as Vice President of Human Resources

BioTech 365

aTyr Pharma Appoints Danielle Campbell as Vice President of Human Resources aTyr Pharma Appoints Danielle Campbell as Vice President of Human Resources SAN DIEGO, Dec. 24, 2021 (GLOBE NEWSWIRE) — aTyr Pharma, Inc.

40
article thumbnail

Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0176 in Prostate Cancer

BioTech 365

Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0176 in Prostate Cancer Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0176 in Prostate Cancer BROOKLYN, N.Y.–(BUSINESS WIRE)–Accutar Biotechnology, Inc.

Trials 52
article thumbnail

#news #biotech Novo Holdings invests €86m in 21st.BIO

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Novo Holdings invests €86m in 21st.BIO. from European Biotechnology – first and foremost in European biotech [link].

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

#news #biotech Season Greetings

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Season Greetings. from European Biotechnology – first and foremost in European biotech [link].

article thumbnail

Terranueva Obtains a Refinancing

BioTech 365

Terranueva Obtains a Refinancing Terranueva Obtains a Refinancing L’ASSOMPTION, Quebec, Dec.

40